FranΓ§aisπ See the interactive version (live chart) β
For McKesson Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 72% were profitable, average return +23% (159 calls). At 3 months: +4% average return (51% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 29 | 79% | +30% |
| Barclays | 13 | 54% | +14% |
| Baird | 12 | 83% | +25% |
| UBS | 11 | 91% | +31% |
| Citigroup | 10 | 90% | +32% |
Is McKesson Corporation overvalued, and is it a good time to buy McKesson Corporation right now? If you're wondering, here's a recap to make up your own mind: McKesson Corporation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | McKesson Corporation | Sector median (Health Care) |
|---|---|---|
| P/E | 24.0 | 29.4 |
| Forward P/E | 17.6 | 17.1 |
| Net margin | 1% | 12% |
π McKesson Corporation trades below its sector median (24.0 vs 29.4) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : McKesson Corporation pays about $3.28/share/yr β 0.43% yield. what is this?
The analyst consensus on McKesson Corporation (MCK) is "Buy" (33 bullish, 0 bearish calls over 12 months). This is not advice: historically, 72% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $1,000 (+12% vs $891), ranging from $845 to $1,080 (9 analysts).
Over 1 year, 72% of analyst targets on McKesson Corporation were profitable, for an average return of +23% (across 159 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $1,000 within 12 months, i.e. +12% vs the current price. The most bullish targets $1,080, the most cautious $845.
Note: analyst targets are 12-month (median $1,000, +12%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (72%), and the stock's past trajectory.
Its P/E is 24.0, forward P/E 17.6. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of McKesson Corporation β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.